Clinical Trials Directory

Trials / Completed

CompletedNCT02797574

Stress Response Pathways in Vitiligo

Stress Response Pathways in Vitiligo: A Prospective, Investigator Initiated, Interventional Study With Two Arms

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate stress response pathways in tissues and melanocytes from patients with vitiligo. Investigators are collecting evidence of UPR and stress response activation in tissues and melanocytes from patients with vitiligo. Individuals with vitiligo will have punch biopsies to study stress response UPR activation and NF-κB signaling to test our hypothesis. In order to characterize differences between disease and normal states, a second arm of control individuals (Arm 2) will be recruited.

Detailed description

Identifying a role for NF-κB signaling in vitiligo may improve therapies for this disfiguring disorder. Current treatments vary in effectiveness and may not always be long lasting cases. The NF-κB pathway and IL-6 itself are the target of several FDA approved drugs, thus opening new therapeutic avenues.

Conditions

Interventions

TypeNameDescription
PROCEDUREPunch Biopsy at a Lesional Site
PROCEDUREPunch Biopsy at a Non- Lesional site

Timeline

Start date
2015-10-01
Primary completion
2021-09-22
Completion
2021-09-22
First posted
2016-06-13
Last updated
2021-11-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02797574. Inclusion in this directory is not an endorsement.